Perpetual Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$18M Buy
35,050
+5,957
+20% +$3.02M 2.15% 9
2022
Q3
$13.2M Sell
29,093
-374
-1% -$179K 1.93% 15
2022
Q2
$14.2M Buy
29,467
+2,048
+7% +$1.01M 2.08% 13
2022
Q1
$13.5M Sell
27,419
-6,556
-19% -$3M 1.69% 14
2021
Q4
$15.7M Buy
33,975
+1,745
+5% +$734K 1.81% 10
2021
Q3
$12M Sell
32,230
-277
-0.9% -$105K 1.52% 11
2021
Q2
$12.4M Buy
32,507
+718
+2% +$274K 1.76% 11
2021
Q1
$11.4M Buy
31,789
+69
+0.2% +$22.2K 1.89% 11
2020
Q4
$9.96M Buy
+31,720
New +$9.73M 1.47% 17

Other funds holding ELV

Perpetual Investment Management's ELV Position: Q4 2022 in Review

Perpetual Investment Management increased its Elevance Health (ELV) stake by 20% in Q4 2022, buying an estimated $3.02M and bringing the position to 35,050 shares worth $18M. The position accounts for 2.15% of the portfolio, ranked #9.

Perpetual Investment Management first reported a position in ELV in Q4 2020 and has held it in 9 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Perpetual Investment Management held 35,050 shares of Elevance Health worth $18M as of Q4 2022.
  • Perpetual Investment Management bought 5,957 Elevance Health shares in Q4 2022, an estimated $3.02M.
  • Elevance Health made up 2.15% of Perpetual Investment Management's portfolio in Q4 2022, its #9 holding.
  • Perpetual Investment Management first reported a position in Elevance Health in Q4 2020 and has held it in 9 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.